Search

Your search keyword '"Sanft, Tara"' showing total 24 results
Start Over Author "Sanft, Tara" Publisher american association for cancer research (aacr)
24 results on '"Sanft, Tara"'

1. Data from Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial

Author

Brown, Justin C., primary, Zhang, Sui, primary, Ligibel, Jennifer A., primary, Irwin, Melinda L., primary, Jones, Lee W., primary, Campbell, Nancy, primary, Pollak, Michael N., primary, Sorrentino, Alexandra, primary, Cartmel, Brenda, primary, Harrigan, Maura, primary, Tolaney, Sara M., primary, Winer, Eric P., primary, Ng, Kimmie, primary, Abrams, Thomas A., primary, Sanft, Tara, primary, Douglas, Pamela S., primary, Hu, Frank B., primary, Fuchs, Charles S., primary, and Meyerhardt, Jeffrey A., primary

Published
2023
Full Text
View/download PDF

2. Supplementary Tables 1 and 2 from Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial

Author

Brown, Justin C., primary, Zhang, Sui, primary, Ligibel, Jennifer A., primary, Irwin, Melinda L., primary, Jones, Lee W., primary, Campbell, Nancy, primary, Pollak, Michael N., primary, Sorrentino, Alexandra, primary, Cartmel, Brenda, primary, Harrigan, Maura, primary, Tolaney, Sara M., primary, Winer, Eric P., primary, Ng, Kimmie, primary, Abrams, Thomas A., primary, Sanft, Tara, primary, Douglas, Pamela S., primary, Hu, Frank B., primary, Fuchs, Charles S., primary, and Meyerhardt, Jeffrey A., primary

Published
2023
Full Text
View/download PDF

3. Data from Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial

Author

Brown, Justin C., primary, Zhang, Sui, primary, Ligibel, Jennifer A., primary, Irwin, Melinda L., primary, Jones, Lee W., primary, Campbell, Nancy, primary, Pollak, Michael N., primary, Sorrentino, Alexandra, primary, Cartmel, Brenda, primary, Harrigan, Maura, primary, Tolaney, Sara M., primary, Winer, Eric P., primary, Ng, Kimmie, primary, Abrams, Thomas A., primary, Sanft, Tara, primary, Douglas, Pamela S., primary, Hu, Frank B., primary, Fuchs, Charles S., primary, and Meyerhardt, Jeffrey A., primary

Published
2023
Full Text
View/download PDF

4. Supplementary Tables 1 and 2 from Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial

Author

Brown, Justin C., primary, Zhang, Sui, primary, Ligibel, Jennifer A., primary, Irwin, Melinda L., primary, Jones, Lee W., primary, Campbell, Nancy, primary, Pollak, Michael N., primary, Sorrentino, Alexandra, primary, Cartmel, Brenda, primary, Harrigan, Maura, primary, Tolaney, Sara M., primary, Winer, Eric P., primary, Ng, Kimmie, primary, Abrams, Thomas A., primary, Sanft, Tara, primary, Douglas, Pamela S., primary, Hu, Frank B., primary, Fuchs, Charles S., primary, and Meyerhardt, Jeffrey A., primary

Published
2023
Full Text
View/download PDF

5. Data from Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

Author

Bardia, Aditya, primary, Hurvitz, Sara A., primary, DeMichele, Angela, primary, Clark, Amy S., primary, Zelnak, Amelia, primary, Yardley, Denise A., primary, Karuturi, Meghan, primary, Sanft, Tara, primary, Blau, Sibel, primary, Hart, Lowell, primary, Ma, Cynthia, primary, Rugo, Hope S., primary, Purkayastha, Das, primary, and Moulder, Stacy, primary

Published
2023
Full Text
View/download PDF

6. Data from Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

Author

Bardia, Aditya, primary, Hurvitz, Sara A., primary, DeMichele, Angela, primary, Clark, Amy S., primary, Zelnak, Amelia, primary, Yardley, Denise A., primary, Karuturi, Meghan, primary, Sanft, Tara, primary, Blau, Sibel, primary, Hart, Lowell, primary, Ma, Cynthia, primary, Rugo, Hope S., primary, Purkayastha, Das, primary, and Moulder, Stacy, primary

Published
2023
Full Text
View/download PDF

7. Supplementary ctDNA Data from Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

Author

Bardia, Aditya, primary, Hurvitz, Sara A., primary, DeMichele, Angela, primary, Clark, Amy S., primary, Zelnak, Amelia, primary, Yardley, Denise A., primary, Karuturi, Meghan, primary, Sanft, Tara, primary, Blau, Sibel, primary, Hart, Lowell, primary, Ma, Cynthia, primary, Rugo, Hope S., primary, Purkayastha, Das, primary, and Moulder, Stacy, primary

Published
2023
Full Text
View/download PDF

8. Suppl Figure from Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

Author

Bardia, Aditya, primary, Hurvitz, Sara A., primary, DeMichele, Angela, primary, Clark, Amy S., primary, Zelnak, Amelia, primary, Yardley, Denise A., primary, Karuturi, Meghan, primary, Sanft, Tara, primary, Blau, Sibel, primary, Hart, Lowell, primary, Ma, Cynthia, primary, Rugo, Hope S., primary, Purkayastha, Das, primary, and Moulder, Stacy, primary

Published
2023
Full Text
View/download PDF

9. Supplementary ctDNA Data from Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

Author

Bardia, Aditya, primary, Hurvitz, Sara A., primary, DeMichele, Angela, primary, Clark, Amy S., primary, Zelnak, Amelia, primary, Yardley, Denise A., primary, Karuturi, Meghan, primary, Sanft, Tara, primary, Blau, Sibel, primary, Hart, Lowell, primary, Ma, Cynthia, primary, Rugo, Hope S., primary, Purkayastha, Das, primary, and Moulder, Stacy, primary

Published
2023
Full Text
View/download PDF

10. Suppl Figure from Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

Author

Bardia, Aditya, primary, Hurvitz, Sara A., primary, DeMichele, Angela, primary, Clark, Amy S., primary, Zelnak, Amelia, primary, Yardley, Denise A., primary, Karuturi, Meghan, primary, Sanft, Tara, primary, Blau, Sibel, primary, Hart, Lowell, primary, Ma, Cynthia, primary, Rugo, Hope S., primary, Purkayastha, Das, primary, and Moulder, Stacy, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Table from Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

Author

Bardia, Aditya, primary, Hurvitz, Sara A., primary, DeMichele, Angela, primary, Clark, Amy S., primary, Zelnak, Amelia, primary, Yardley, Denise A., primary, Karuturi, Meghan, primary, Sanft, Tara, primary, Blau, Sibel, primary, Hart, Lowell, primary, Ma, Cynthia, primary, Rugo, Hope S., primary, Purkayastha, Das, primary, and Moulder, Stacy, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Table from Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

Author

Bardia, Aditya, primary, Hurvitz, Sara A., primary, DeMichele, Angela, primary, Clark, Amy S., primary, Zelnak, Amelia, primary, Yardley, Denise A., primary, Karuturi, Meghan, primary, Sanft, Tara, primary, Blau, Sibel, primary, Hart, Lowell, primary, Ma, Cynthia, primary, Rugo, Hope S., primary, Purkayastha, Das, primary, and Moulder, Stacy, primary

Published
2023
Full Text
View/download PDF

13. Abstract PD12-01: PD12-01 Impact of obesity and post-diagnosis weight change on survival in women with breast cancer diagnosed at Smilow Cancer Hospital from 2013-2019

Author

Puklin, Leah, primary, Li, Fangyong, additional, Cartmel, Brenda, additional, Sanft, Tara B., additional, Lisevick, Alexa, additional, Winer, Eric, additional, Lustberg, Maryam, additional, Sharifi, Mona, additional, Irwin, Melinda L., additional, and Ferrucci, Leah, additional

Published
2023
Full Text
View/download PDF

14. Abstract PD12-08: PD12-08 Randomized trial of exercise and nutrition on pathological complete response among women with breast cancer receiving neoadjuvant chemotherapy: the Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) Study

Author

Ferrucci, Leah, primary, Sanft, Tara B., additional, Harrigan, Maura, additional, Cartmel, Brenda, additional, Li, Fangyong, additional, Zupa, Michelle, additional, McGowan, Courtney, additional, Puklin, Leah, additional, Nguyen, Thai Hien, additional, Tanasijevic, Anna M., additional, Neuhouser, Marian L., additional, Hershman, Dawn, additional, Basen-Engquist, Karen, additional, Jones, Beth, additional, Knobf, Tish, additional, Chagpar, Anees B., additional, Silber, Andrea L.M., additional, Ligibel, Jennifer A., additional, and Irwin, Melinda L., additional

Published
2023
Full Text
View/download PDF

17. Abstract OT1-10-01: The Breast Cancer Index registry study: A prospective multi-center observational study to evaluate patient outcome, clinical impact, and medication adherence in HR+ breast cancer patients considering treatment with extended endocrine therapy

Author

O'Shaughnessy, Joyce A, primary, Fox, Jenny R, additional, Encarnación, Carlos A, additional, O'Neal, Brandon, additional, Treuner, Kai, additional, Sanft, Tara, additional, Jankowitz, Rachel C, additional, Pegram, Mark D, additional, Schnabel, Catherine A, additional, and Diab, Sami G, additional

Published
2022
Full Text
View/download PDF

18. Abstract PD13-03: Ribociclib, everolimus, exemestane triplet therapy in HR+/HER2− advanced breast cancer after progression on a CDK4/6 inhibitor: Final efficacy, safety, and biomarker results from TRINITI-1

Author

Hurvitz, Sara A., primary, Clark, Amy S., additional, Rugo, Hope S., additional, Bardia, Aditya, additional, Zelnak, Amelia, additional, Yardley, Denise A., additional, Karuturi, Meghan, additional, Sanft, Tara, additional, Blau, Sibel, additional, Hart, Lowell, additional, Ma, Cynthia, additional, Purkayastha, Das, additional, Eppig, Colleen, additional, and DeMichele, Angela, additional

Published
2022
Full Text
View/download PDF

19. Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

Author

Bardia, Aditya, primary, Hurvitz, Sara A., additional, DeMichele, Angela, additional, Clark, Amy S., additional, Zelnak, Amelia, additional, Yardley, Denise A., additional, Karuturi, Meghan, additional, Sanft, Tara, additional, Blau, Sibel, additional, Hart, Lowell, additional, Ma, Cynthia, additional, Rugo, Hope S., additional, Purkayastha, Das, additional, and Moulder, Stacy, additional

Published
2021
Full Text
View/download PDF

21. Abstract PS8-17: Assessing effect modification of obesity-associated genes variants in FTO, MC4R, BDNF, and CREB1 on weight loss among breast cancer survivors enrolled in the randomized lifestyle, exercise, and nutrition (LEAN) study

Author

Nguyen, ThaiHien, primary, Irwin, Melinda L, additional, Dewan, Andrew T, additional, Harrigan, Maura, additional, Cartmel, Brenda, additional, Sanft, Tara, additional, Lu, Lingeng, additional, Li, Fangyong, additional, and Salinas, Yasmmyn D, additional

Published
2021
Full Text
View/download PDF

22. Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial

Author

Brown, Justin C., primary, Zhang, Sui, additional, Ligibel, Jennifer A., additional, Irwin, Melinda L., additional, Jones, Lee W., additional, Campbell, Nancy, additional, Pollak, Michael N., additional, Sorrentino, Alexandra, additional, Cartmel, Brenda, additional, Harrigan, Maura, additional, Tolaney, Sara M., additional, Winer, Eric P., additional, Ng, Kimmie, additional, Abrams, Thomas A., additional, Sanft, Tara, additional, Douglas, Pamela S., additional, Hu, Frank B., additional, Fuchs, Charles S., additional, and Meyerhardt, Jeffrey A., additional

Published
2020
Full Text
View/download PDF

23. Abstract P3-09-02: Evaluation of a novel agent plus standard neoadjuvant therapy in early stage, high-risk HER2 negative breast cancer: Results from the I-SPY 2 TRIAL

Author

Liu, Minetta C., primary, Robinson, Patricia A, additional, Yau, Christina, additional, Wallace, Anne M, additional, Chien, A. Jo, additional, Stringer-Reasor, Erica, additional, Nanda, Rita, additional, Yee, Douglas, additional, Albain, Kathy S, additional, Boughey, Judy C, additional, Han, Heather S, additional, Elias, Anthony D, additional, Kalinsky, Kevin, additional, Clark, Amy S, additional, Kemmer, Kathleen, additional, Isaacs, Claudine, additional, Lang, Julie E, additional, Lu, Janice, additional, Sanft, Tara, additional, DeMichele, Angela, additional, Hylton, Nola M, additional, Melisko, Michelle E, additional, Perlmutter, Jane, additional, Rugo, Hope S, additional, Schwab, Richard, additional, Symmans, W. Fraser, additional, van't Veer, Laura J, additional, Haugen, Patricia K, additional, Wilson, Amy, additional, Singhrao, Ruby, additional, Asare, Smita, additional, Sanil, Ashish, additional, Berry, Donald A, additional, and Esserman, Laura J, additional

Published
2020
Full Text
View/download PDF

24. Abstract P5-13-02: Neoadjuvant aromatase inhibitor therapy plus the mTOR inhibitor everolimus in postmenopausal women with hormone receptor positive/HER2 negative breast cancer and an oncotype Dx recurrence score (≤25)

Author

Abu-Khalaf, Maysa M, primary, Aderhold, Kimberly, additional, Marczyk, Michal, additional, Chung, Gina, additional, Hofstatter, Erin, additional, Sanft, Tara, additional, Silber, Andrea, additional, DiGiovanna, Michael, additional, Zelterman, Daniel, additional, Puzstai, Lajos, additional, and Hatzis, Christos, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results